With the aim of identifying biomarkers of renal fibrosis to help predict disease progression, a recent systematic review concluded that MCP-1 may identify patients at risk of developing renal fibrosis and having a worse prognosis [88]. This evidence concerns the gene CCL2 and renal fibrosis.